LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Moderna Inc

Geschlossen

BrancheGesundheitswesen

27.46 5.21

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

26.09

Max

27.54

Schlüsselkennzahlen

By Trading Economics

Einkommen

149M

-971M

Verkäufe

-859M

107M

KGV

Branchendurchschnitt

35.86

51.198

EPS

-2.52

Gewinnspanne

-907.477

Angestellte

5,800

EBITDA

194M

-924M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+79.5% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-2.1B

10B

Vorheriger Eröffnungskurs

22.25

Vorheriger Schlusskurs

27.46

Nachrichtenstimmung

By Acuity

100%

0%

369 / 380 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Moderna Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Juni 2025, 10:41 UTC

Wichtige Markttreiber

Moderna Shares Rise on FDA Approval of Covid-19 Vaccine

31. März 2025, 14:19 UTC

Wichtige Markttreiber

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4. Feb. 2025, 18:52 UTC

Wichtige Markttreiber

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

27. Mai 2025, 17:59 UTC

Top News

Kennedy, Skipping Regulatory Steps, Limits Use of Covid-19 Shots -- Barrons.com

12. Mai 2025, 22:14 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12. Mai 2025, 18:45 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- Update

12. Mai 2025, 17:14 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- WSJ

28. Apr. 2025, 17:04 UTC

Ergebnisse

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. -- Barrons.com

28. Feb. 2025, 12:00 UTC

Top News

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

24. Feb. 2025, 10:17 UTC

Heiße Aktien

Stocks to Watch Monday: Domino's, Berkshire Hathaway; Alibaba -- WSJ

14. Feb. 2025, 22:04 UTC

Ergebnisse

These Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14. Feb. 2025, 20:26 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14. Feb. 2025, 17:34 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More -- Barrons.com

14. Feb. 2025, 15:42 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DraftKings, GameStop, and More -- Barrons.com

14. Feb. 2025, 14:02 UTC

Top News
Ergebnisse

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. -- Barrons.com

14. Feb. 2025, 11:38 UTC

Top News
Ergebnisse

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14. Feb. 2025, 11:34 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Intel, Airbnb, DraftKings, GameStop, Moderna, Roku, Palo Alto, and More -- Barrons.com

14. Feb. 2025, 11:30 UTC

Top News
Ergebnisse

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

4. Feb. 2025, 19:34 UTC

Top News

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4. Feb. 2025, 18:51 UTC

Top News

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

21. Jan. 2025, 10:12 UTC

Heiße Aktien

Stocks to Watch Tuesday: MicroStrategy, Trump Media, Moderna, Ørsted -- WSJ

13. Jan. 2025, 13:51 UTC

Ergebnisse

Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast. -- Barrons.com

8. Jan. 2025, 09:43 UTC

Heiße Aktien

Stocks to Watch Wednesday: Moderna, Nvidia, Albertsons, Flutter -- WSJ

15. Nov. 2024, 19:24 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

15. Nov. 2024, 17:23 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More -- Barrons.com

15. Nov. 2024, 15:43 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Alibaba, Bloom Energy, and More -- Barrons.com

15. Nov. 2024, 13:34 UTC

Top News

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15. Nov. 2024, 13:08 UTC

Top News

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

15. Nov. 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

15. Nov. 2024, 10:34 UTC

Market Talk

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

Peer-Vergleich

Kursveränderung

Moderna Inc Prognose

Kursziel

By TipRanks

79.5% Vorteil

12-Monats-Prognose

Durchschnitt 49.29 USD  79.5%

Hoch 198 USD

Tief 25 USD

Basierend auf 20 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moderna Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

20 ratings

4

Buy

13

Halten

3

Sell

Technischer Score

By Trading Central

23.7 / 27.88Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

369 / 380 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.